• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用深度学习揭示导管原位癌的免疫微生态。

Unmasking the immune microecology of ductal carcinoma in situ with deep learning.

作者信息

Narayanan Priya Lakshmi, Raza Shan E Ahmed, Hall Allison H, Marks Jeffrey R, King Lorraine, West Robert B, Hernandez Lucia, Guppy Naomi, Dowsett Mitch, Gusterson Barry, Maley Carlo, Hwang E Shelley, Yuan Yinyin

机构信息

Centre for Evolution and Cancer, Institute of Cancer Research, London, UK.

Division of Molecular Pathology, Institute of Cancer Research, London, UK.

出版信息

NPJ Breast Cancer. 2021 Mar 1;7(1):19. doi: 10.1038/s41523-020-00205-5.

DOI:10.1038/s41523-020-00205-5
PMID:33649333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7921670/
Abstract

Despite increasing evidence supporting the clinical relevance of tumour infiltrating lymphocytes (TILs) in invasive breast cancer, TIL spatial variability within ductal carcinoma in situ (DCIS) samples and its association with progression are not well understood. To characterise tissue spatial architecture and the microenvironment of DCIS, we designed and validated a new deep learning pipeline, UNMaSk. Following automated detection of individual DCIS ducts using a new method IM-Net, we applied spatial tessellation to create virtual boundaries for each duct. To study local TIL infiltration for each duct, DRDIN was developed for mapping the distribution of TILs. In a dataset comprising grade 2-3 pure DCIS and DCIS adjacent to invasive cancer (adjacent DCIS), we found that pure DCIS cases had more TILs compared to adjacent DCIS. However, the colocalisation of TILs with DCIS ducts was significantly lower in pure DCIS compared to adjacent DCIS, which may suggest a more inflamed tissue ecology local to DCIS ducts in adjacent DCIS cases. Our study demonstrates that technological developments in deep convolutional neural networks and digital pathology can enable an automated morphological and microenvironmental analysis of DCIS, providing a new way to study differential immune ecology for individual ducts and identify new markers of progression.

摘要

尽管越来越多的证据支持肿瘤浸润淋巴细胞(TILs)在浸润性乳腺癌中的临床相关性,但导管原位癌(DCIS)样本中TIL的空间变异性及其与进展的关联仍未得到充分了解。为了表征DCIS的组织空间结构和微环境,我们设计并验证了一种新的深度学习管道UNMaSk。在使用新方法IM-Net自动检测单个DCIS导管后,我们应用空间镶嵌为每个导管创建虚拟边界。为了研究每个导管的局部TIL浸润情况,我们开发了DRDIN来绘制TIL的分布。在一个包含2-3级纯DCIS和浸润性癌旁DCIS(相邻DCIS)的数据集里,我们发现纯DCIS病例的TIL比相邻DCIS更多。然而,与相邻DCIS相比,纯DCIS中TIL与DCIS导管的共定位显著更低,这可能表明相邻DCIS病例中DCIS导管局部的组织生态炎症更严重。我们的研究表明,深度卷积神经网络和数字病理学的技术发展能够对DCIS进行自动形态学和微环境分析,可以为研究单个导管的差异免疫生态和识别新的进展标志物提供新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/bb9d76648703/41523_2020_205_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/1aca0dae594a/41523_2020_205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/1d8239836b16/41523_2020_205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/999333d3b4b4/41523_2020_205_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/3b1413c17e89/41523_2020_205_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/cb6171b46ea3/41523_2020_205_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/4a29ecca3581/41523_2020_205_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/6a0c8a08b0e8/41523_2020_205_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/bb9d76648703/41523_2020_205_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/1aca0dae594a/41523_2020_205_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/1d8239836b16/41523_2020_205_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/999333d3b4b4/41523_2020_205_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/3b1413c17e89/41523_2020_205_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/cb6171b46ea3/41523_2020_205_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/4a29ecca3581/41523_2020_205_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/6a0c8a08b0e8/41523_2020_205_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4994/7921670/bb9d76648703/41523_2020_205_Fig8_HTML.jpg

相似文献

1
Unmasking the immune microecology of ductal carcinoma in situ with deep learning.利用深度学习揭示导管原位癌的免疫微生态。
NPJ Breast Cancer. 2021 Mar 1;7(1):19. doi: 10.1038/s41523-020-00205-5.
2
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.肿瘤浸润淋巴细胞分析揭示了原位乳腺导管癌的两个新的生物学不同亚群。
BMC Cancer. 2018 Feb 3;18(1):129. doi: 10.1186/s12885-018-4013-6.
3
Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.导管原位癌的免疫微环境:与乳腺浸润性癌的比较。
Breast Cancer Res. 2020 Mar 26;22(1):32. doi: 10.1186/s13058-020-01267-w.
4
Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.乳腺导管原位癌中肿瘤浸润性B淋巴细胞的预后意义
Histopathology. 2017 Aug;71(2):258-268. doi: 10.1111/his.13217. Epub 2017 May 26.
5
Touching tumour-infiltrating lymphocytes in low-risk ductal carcinoma in situ (DCIS) correlate with upgrading to high-grade DCIS.低危型乳腺导管原位癌(DCIS)中浸润淋巴细胞的检出与向高级别 DCIS 升级相关。
Histopathology. 2022 Jan;80(2):291-303. doi: 10.1111/his.14539. Epub 2021 Sep 22.
6
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.肿瘤浸润淋巴细胞对乳腺导管原位癌的预后意义。
Mod Pathol. 2018 Aug;31(8):1226-1236. doi: 10.1038/s41379-018-0040-8. Epub 2018 Mar 20.
7
Tumour-infiltrating lymphocytes in ductal carcinoma in situ (DCIS)-assessment with three different methodologies and correlation with Oncotype DX DCIS Score.导管原位癌(DCIS)中浸润淋巴细胞的评估——三种不同方法学的评估及与 Oncotype DX DCIS 评分的相关性。
Histopathology. 2020 Nov;77(5):749-759. doi: 10.1111/his.14181. Epub 2020 Sep 26.
8
Higher densities of tumour-infiltrating lymphocytes and CD4 T cells predict recurrence and progression of ductal carcinoma in situ of the breast.肿瘤浸润淋巴细胞和 CD4 T 细胞密度较高,预示着乳腺导管原位癌的复发和进展。
Histopathology. 2020 May;76(6):852-864. doi: 10.1111/his.14055.
9
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial.肿瘤浸润淋巴细胞为低风险导管原位癌患者增加预后信息:来自瑞典导管原位癌随机放疗试验的结果
Eur J Cancer. 2022 Jun;168:128-137. doi: 10.1016/j.ejca.2022.01.016. Epub 2022 Feb 27.
10
Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast.多国原位导管癌(DCIS)队列中的肿瘤浸润淋巴细胞。
Cancers (Basel). 2022 Aug 13;14(16):3916. doi: 10.3390/cancers14163916.

引用本文的文献

1
Deep learning-based risk stratification of ductal carcinoma using mammography and abbreviated breast magnetic resonance imaging.基于深度学习的乳腺导管癌风险分层:使用乳房X线摄影和简化乳腺磁共振成像
Front Oncol. 2025 Jun 24;15:1587882. doi: 10.3389/fonc.2025.1587882. eCollection 2025.
2
Advanced Deep Learning Approaches in Detection Technologies for Comprehensive Breast Cancer Assessment Based on WSIs: A Systematic Literature Review.基于全切片图像的乳腺癌综合评估检测技术中的先进深度学习方法:一项系统文献综述
Diagnostics (Basel). 2025 Apr 30;15(9):1150. doi: 10.3390/diagnostics15091150.
3
Artificial Intelligence in Histologic Diagnosis of Ductal Carcinoma In Situ.

本文引用的文献

1
Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent.乳腺导管原位癌的免疫反应和基质变化与亚型相关。
Mod Pathol. 2020 Sep;33(9):1773-1782. doi: 10.1038/s41379-020-0553-9. Epub 2020 Apr 27.
2
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma to Invasive Ductal Carcinoma.非低级别导管癌进展为浸润性导管癌的全外显子组测序分析。
Clin Cancer Res. 2020 Jul 15;26(14):3682-3693. doi: 10.1158/1078-0432.CCR-19-2563. Epub 2020 Mar 27.
3
A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk.
人工智能在导管原位癌组织学诊断中的应用
Mayo Clin Proc Digit Health. 2023 Jun 25;1(3):267-275. doi: 10.1016/j.mcpdig.2023.05.008. eCollection 2023 Sep.
4
AI in Histopathology Explorer for comprehensive analysis of the evolving AI landscape in histopathology.组织病理学中的人工智能探索器,用于全面分析组织病理学中不断发展的人工智能格局。
NPJ Digit Med. 2025 Mar 12;8(1):156. doi: 10.1038/s41746-025-01524-2.
5
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.一种用于识别进展风险较低的导管原位癌的形态计量学特征。
NPJ Precis Oncol. 2025 Jan 28;9(1):25. doi: 10.1038/s41698-024-00769-6.
6
The Microenvironment in DCIS and Its Role in Disease Progression.导管原位癌中的微环境及其在疾病进展中的作用。
Adv Exp Med Biol. 2025;1464:211-235. doi: 10.1007/978-3-031-70875-6_12.
7
Advancing precision medicine: the transformative role of artificial intelligence in immunogenomics, radiomics, and pathomics for biomarker discovery and immunotherapy optimization.推进精准医学:人工智能在免疫基因组学、放射组学和病理组学中对生物标志物发现及免疫治疗优化的变革性作用。
Cancer Biol Med. 2025 Jan 2;22(1):33-47. doi: 10.20892/j.issn.2095-3941.2024.0376.
8
Invasive carcinoma segmentation in whole slide images using MS-ResMTUNet.使用MS-ResMTUNet对全切片图像中的浸润性癌进行分割。
Heliyon. 2024 Feb 19;10(4):e26413. doi: 10.1016/j.heliyon.2024.e26413. eCollection 2024 Feb 29.
9
Computational pathology: A survey review and the way forward.计算病理学:综述与未来发展方向
J Pathol Inform. 2024 Jan 14;15:100357. doi: 10.1016/j.jpi.2023.100357. eCollection 2024 Dec.
10
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.基于人工智能的形态计量学特征用于识别原位导管癌,其进展为浸润性乳腺癌的风险较低。
Res Sq. 2023 Dec 13:rs.3.rs-3639521. doi: 10.21203/rs.3.rs-3639521/v1.
基于全 slides 图像的机器学习方法预测导管原位癌 (DCIS) 复发风险。
Breast Cancer Res. 2019 Jul 29;21(1):83. doi: 10.1186/s13058-019-1165-5.
4
Ductal carcinoma in situ: to treat or not to treat, that is the question.导管原位癌:治疗还是不治疗,这是个问题。
Br J Cancer. 2019 Aug;121(4):285-292. doi: 10.1038/s41416-019-0478-6. Epub 2019 Jul 9.
5
Micro-Net: A unified model for segmentation of various objects in microscopy images.微网:用于显微镜图像中各种对象分割的统一模型。
Med Image Anal. 2019 Feb;52:160-173. doi: 10.1016/j.media.2018.12.003. Epub 2018 Dec 15.
6
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.肿瘤浸润淋巴细胞分析揭示了原位乳腺导管癌的两个新的生物学不同亚群。
BMC Cancer. 2018 Feb 3;18(1):129. doi: 10.1186/s12885-018-4013-6.
7
Ductal Carcinoma Biology, Biomarkers, and Diagnosis.导管癌生物学、生物标志物与诊断
Front Oncol. 2017 Oct 23;7:248. doi: 10.3389/fonc.2017.00248. eCollection 2017.
8
Classifying the evolutionary and ecological features of neoplasms.对肿瘤的进化和生态特征进行分类。
Nat Rev Cancer. 2017 Oct;17(10):605-619. doi: 10.1038/nrc.2017.69. Epub 2017 Sep 15.
9
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer.免疫浸润的空间异质性对预测ER+乳腺癌内分泌治疗后复发风险的相关性
J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx137.
10
Immune Escape in Breast Cancer During to Invasive Carcinoma Transition.乳腺癌从原位癌向浸润性癌转变过程中的免疫逃逸
Cancer Discov. 2017 Oct;7(10):1098-1115. doi: 10.1158/2159-8290.CD-17-0222. Epub 2017 Jun 26.